Showing results (331-340 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|February 14, 2022
Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and OpportunitiesMahnaz Rezaei, Natalia D Danilova, Mojdeh Soltani, et al.Current Cancer Drug Targets|February 25, 2022
The Current and Evolving Role of Immunotherapy in Metastatic Colorectal CancerVirgilio S Silva, Rachel P Riechelmann, Celso A Mello, et al.Current Cancer Drug Targets|January 27, 2022
Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer CellsSina M Matalqah, Khalid Aiedeh, Nizar M Mhaidat, et al.Current Cancer Drug Targets|February 4, 2022
CEA-regulated Oncolytic Virus Anticancer Therapy: A Promising Strategy for Rare Solid TumorsYuqi Yang, Shuhang Wang, Peiwen Ma, et al.Current Cancer Drug Targets|January 26, 2022
Combined Transarterial Chemoembolization with Microwave Ablation versus Microwave Alone for Treatment of Medium Sized Hepatocellular CarcinomaWaleed El-Agawy, Sara Ahmed El-Ganainy, Magdy Abd Almawgoud Gad, et al.Current Cancer Drug Targets|January 26, 2022
Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived OrganoidsLing Ding, Yuning Yang, Qin Lu, et al.Current Cancer Drug Targets|March 18, 2022
Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular CarcinomaAyana R Kumar, Aswathy R Devan, Bhagyalakshmi Nair, et al.Current Cancer Drug Targets|March 18, 2022
Current Treatment and Future Trends of Immunotherapy in Breast CancerMitchell J Elliott, Brooke Wilson, David W CesconCurrent Cancer Drug Targets|September 6, 2018
c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 ExpressionMerve Aksoz, Esra Albayrak, Galip Servet Aslan, et al.Current Cancer Drug Targets|September 13, 2018
In Vitro and In Vivo Antimetastatic Effects of ZSTK474 on Prostate Cancer DU145 CellsJie Liu, Xiao Tan, Wennan Zhao, et al.Pageof 187